Cite
Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis.
MLA
Canto-Gomes, João, et al. “Distinct Disease-Modifying Therapies Are Associated with Different Blood Immune Cell Profiles in People with Relapsing-Remitting Multiple Sclerosis.” International Immunopharmacology, vol. 131, Apr. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.111826.
APA
Canto-Gomes, J., Boleixa, D., Teixeira, C., Martins da Silva, A., González-Suárez, I., Cerqueira, J., Correia-Neves, M., & Nobrega, C. (2024). Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis. International Immunopharmacology, 131, N.PAG. https://doi.org/10.1016/j.intimp.2024.111826
Chicago
Canto-Gomes, João, Daniela Boleixa, Catarina Teixeira, Ana Martins da Silva, Inés González-Suárez, João Cerqueira, Margarida Correia-Neves, and Claudia Nobrega. 2024. “Distinct Disease-Modifying Therapies Are Associated with Different Blood Immune Cell Profiles in People with Relapsing-Remitting Multiple Sclerosis.” International Immunopharmacology 131 (April): N.PAG. doi:10.1016/j.intimp.2024.111826.